YAN Qingya, LU Yiqin, XIAO Chengzong. TCM master Xiao Chengzong’s experience in treating infertility due to premature ovarian failure. [J]. Modern Chinese Clinical Medicine 30(2):10-15(2023)
DOI:
YAN Qingya, LU Yiqin, XIAO Chengzong. TCM master Xiao Chengzong’s experience in treating infertility due to premature ovarian failure. [J]. Modern Chinese Clinical Medicine 30(2):10-15(2023) DOI: 10.3969/j.issn.2095-6606.2023.02.003.
TCM master Xiao Chengzong’s experience in treating infertility due to premature ovarian failure
and decreased estrogen levels in women aged below 40 years
accompanied by varying degrees of perimenopausal symptoms
which is the final stage of ovarian dysfunction. Professor Xiao Chengzong believes that the core pathogenesis of premature ovarian failure lies in kidney deficiency and Thoroughfare Vessel disharmony. Her treatment of premature ovarian failure is based on the principle of tonifying the kidney and regulating the Thoroughfare Vessel. She has prepared Qizi Yishen Lichong Decoction(七子益肾理冲汤) as the basic formula. In clinical practice
she integrates traditional Chinese medicine and Western medicine
and attaches importance to the "real opportunity period" . Once the pregnancy occurs
priority is given to the prevention of miscarriage as early as possible.This paper introduces Professor Xiao’s experience in treating infertility caused by premature ovarian failure with Qizi Yishen Lichong Decoction
Gushen Antai Berverage(固肾安胎饮)
etc.
in combination with Western medicine. Then Professor Xiao’s diagnosis and treatment and medication ideas are presented through clinical cases.
关键词
卵巢早衰不孕症益肾理冲名医经验肖承悰
Keywords
premature ovarian failureinfertilitytonifying the kidney and regulating Thoroughfare Vesselfamous physicians’ experienceXiao Chengzong
references
谢幸,孔北华,段涛.妇产科学[M].9版.北京:人民卫生出版社,2018: 358-360.
KOKCU A. Premature ovarian failure from current perspective[J]. Gynecol Endocrinol,2010,26(8): 555-562.
TAN T Y,LAU S K,LOH S F,et al. Female ageing and reproductive outcome in assisted reproduction cycles[J]. Singapore Med J,2014,55(6): 305-309.
MAMAS L,MAMAS E. Premature ovarian failure and dehydroepiandrosterone[J]. Fertil Steril,2009,91(2): 644-646.
SCHMIDT K T,ROSENDAHL M,ERNST E,et al. Autotransplantation of cryopreserved ovarian tissue in 12 women with chemotherapy-induced premature ovarian failure: the Danish experience[J]. Fertil Steril, 2011,95(2): 695-701.
THE NAMS 2017 HORMONE THERAPY POSITION STATEMENT ADVISORY PANEL.The 2017 hormone therapy position statement of The North American Menopause Society[J]. Menopause,2017,24(7): 728-753.
LIU T,LI Q,WANG S,et al. Transplantation of ovarian granulosalike cells derived from human induced pluripotent stem cells for the treatment of murine premature ovarian failure[J]. Mol Med Rep, 2016,13(6): 5053-5058.